Cite

MLA Citation

    Janne Estill and Barbara Bertisch. “More evidence for dolutegravir as first-line ART for all.” Lancet, vol. 7, no. 3, 2020, pp. e154–e155. http://access.bl.uk/ark:/81055/vdc_100103932538.0x000014
  
Back to record